Hormonal
Semaglutide produces greater weight loss than liraglutide but is associated with more intense gastrointestinal adverse effects, particularly nausea and vomiting.
If you are choosing between semaglutide and liraglutide for weight loss, expect semaglutide to deliver better results but with more intense stomach issues like nausea and vomiting. These side effects are usually mild or moderate and tend to decrease over time. If you have a sensitive stomach, liraglutide might be better tolerated, but you may lose less weight.
The use of semaglutide seems to be linked to side effects, especially in the gastrointestinal tract, of greater intensity when compared to liraglutide. However, weight loss was shown to be greater in semaglutide users.
Why this rating
The paper is an integrative review of 12 studies, not a single head-to-head trial, limiting direct comparative statistical power.
Source
Efeitos adversos da semaglutida comparada à liraglutida: uma revisão integrativa de literatura
Ana Laura Silva Machado de Moraes et al. · Research Society and Development · 2022
DOI 10.33448/rsd-v11i10.33181
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →